play_arrow

keyboard_arrow_right

replay_10 skip_previous play_arrow skip_next forward_10
00:00 00:00
playlist_play chevron_left
volume_up
chevron_left
play_arrow

Pat(i)ent Rights

Devina Sengupta May 11, 2021


Background
share close

A waiver of intellectual property rights on Covid-19 vaccines and drugs alone may not benefit developing countries including India in the battle against the deadly disease. Murali Neelakantan, Former Global General Counsel of Cipla and Glenmark, and Vikas Dandekar, Editor, Pharma and Healthcare, ET Prime, explain what’s at stake for the patent holders and developing nations. The clip featuring Bill Gates used in the podcast belongs to Sky News.

Credits : Editor - Nehal Chaliawala, Producer - Surbhi Modi, Sound Editor - Swati Joshi, Coordinator - Bhavya Dilipkumar